Entering text into the input field will update the search result below

Accelerate Diagnostics' (AXDX) CEO Lawrence Mehren on Q3 2017 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q3 2017 Earnings Conference Call November 2, 2017 4:15 PM ET


Laura Pierson - IR

Lawrence Mehren - CEO, President and Director

Steve Reichling - CFO, CAO and Secretary


William Quirk - Piper Jaffray Companies

Steven Reiman - JPMorgan Chase & Co.

Brian Weinstein - William Blair & Company


Good day, and welcome to the Accelerate Diagnostics, Inc. 2017 Q3 Results Conference Call. [Operator Instructions]. Please note this event is being recorded. I would now like to turn the conference over to Laura Pierson of Accelerate Diagnostics. Please go ahead.

Laura Pierson

Before we begin, I would like to advise you that information presented during this conference call may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include statements about our future and statements that are not historical facts. These statements may contain expectations regarding revenues, earnings, operations and other results and may include statements of future performance, plans and objectives.

Forward-looking statements include statements pertaining to, among other things, the commercial launch and demand for the Accelerate Pheno system and Accelerate PhenoTest BC kit for positive blood cultures; the potential benefits of the Accelerate Pheno system and Accelerate PhenoTest BC kit, including accelerated identification and susceptibility results and estimates of time reduction to results; expectations on placements, sales and product profitability; the potential of our technology generally; our belief that our expanded manufacturing capability will allow us to meet demand; our expectation of our 2017 and 2018 performance and our future development plans and growth strategy, including with respect to research and development as well as product expansion. These statements represent only our belief regarding future events, many of which are inherently uncertain.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.